Value of Clinical Evidence and Health Economics and Outcomes Research (HEOR) Studies. [PDF]
Muscle NerveAbrahao A, Ciepielewska M, Zinman L.
europepmc +1 more source
Beyond the label: ethical and clinical implications of off-label drug use in pediatric emergency care. [PDF]
Ital J PediatrColombo M, Plebani A, Agosti M.
europepmc +1 more source
Effectiveness of Maternal Respiratory Syncytial Virus Vaccination in Conferring Infant Immunity: Review and Future Perspectives. [PDF]
Vaccines (Basel)Kaneko M, Muraoka J.
europepmc +1 more source
Reply : Primary suspect drugs of cataracts in pediatric patients: FDA adverse events reporting database analysis. [PDF]
J Cataract Refract SurgKhan SM +3 more
europepmc +1 more source
A review of clinical pharmacology considerations in antibody-drug conjugates approved by the US Food and Drug Administration between 2000 and 2025. [PDF]
Transl Clin PharmacolKoo S +6 more
europepmc +1 more source
Evolving Real-World Data and Evidence Use for New Drugs and Regenerative Medical Products Approvals in Japan-An Analysis of the 6-Year Trend. [PDF]
Clin Pharmacol TherOkami S, Shimotsumagari K, Sadatsuki Y.
europepmc +1 more source
A practical framework to approach the development and evaluation of patient registries for rare diseases. [PDF]
Orphanet J Rare DisVaishnaw MS, Richesson R.
europepmc +1 more source
Safety profile and potential clinical risks of xanomeline and trospium chloride: A real-world pharmacovigilance study using FAERS. [PDF]
NeurotherapeuticsBao Z, Liu Y, Liu Y.
europepmc +1 more source
Dose Optimization in Oncology Drug Development: Risk Factors for Postmarketing Requirements and Commitments. [PDF]
Clin Pharmacol TherKitagaki H, Takeda K, Murai K, Maeda H.
europepmc +1 more source